Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Clinical status of CS-834

Feb. 23, 1998

Idec RSV antibodies covered by U.S. patents; development partners sought

Feb. 23, 1998

Rifaximin receives orphan drug status in hepatic encephalopathy

Feb. 23, 1998

SKB evaluates RF-1 as antibacterial target

Feb. 23, 1998

Advisory panel recommends approval of Synercid

Feb. 20, 1998

Glaxo Wellcome enrolls patients in phase III flu drug trials

Feb. 20, 1998

Shionogi investigates new cephem compounds

Feb. 19, 1998

KY-62 evaluated in murine models of candidiasis

Feb. 18, 1998

Cubist outlines development plans for daptomycin

Feb. 18, 1998

SKB and WHO join forces to wipe out lymphatic filariasis

Feb. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...